Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori.
Caspian J Intern Med
; 10(2): 211-216, 2019.
Article
de En
| MEDLINE
| ID: mdl-31363400
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Clinical_trials
/
Risk_factors_studies
Langue:
En
Journal:
Caspian J Intern Med
Année:
2019
Type de document:
Article
Pays d'affiliation:
Iran
Pays de publication:
Iran